French Minister of State for the Economy, Agnes Pagnier-Ronchaire, said that granting some countries such as the United States a priority in obtaining a drug to treat a corona virus developed by the company “Sanofi” would not be acceptable.
Of course, it will not be acceptable for us to have discrimination for one country or another under the pretext of financial motivation, especially in the current context, ”the minister added to Radio Sud, noting that she had contacted the company and received assurances that the vaccine would be available to all countries in which it is located. Manufacturing headquarters, including France.
In turn, French Health Minister Olivier Ferrand said that his talk with Sanofi president “reassured him.”
“I think it was a phrase, as I understand it, somewhat incompatible and it may have been taken out of context, and I am very satisfied after speaking to the Sanofi president,” he added in comments to CNN.
On Wednesday, CEO of the French pharmaceutical company, Paul Hudson, said that the drug doses manufactured in the United States were intended for American patients first because the country provided financial support for research.
Source: Agencies
